Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interviews With Older People From Turkish Origin in Belgium About Advance Care Planning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03930823
Recruitment Status : Recruiting
First Posted : April 29, 2019
Last Update Posted : April 3, 2020
Sponsor:
Information provided by (Responsible Party):
Universitair Ziekenhuis Brussel

Tracking Information
First Submitted Date  ICMJE April 17, 2019
First Posted Date  ICMJE April 29, 2019
Last Update Posted Date April 3, 2020
Actual Study Start Date  ICMJE March 18, 2019
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 25, 2019)
  • Knowledge about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: What do you know in relation to advance care planning?
  • Experiences about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions:Have you yourself ever thought about your future healthcare? Have you yourself ever looked up something about that?
  • Views/preferences about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: What do you think about discussing advance care planning now for the future? Even if you do not have such a serious illness at the moment, what are the advantages and disadvantages about discussing your wishes for the future, now?
  • Attitudes about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: Before you got severe illness, do you wish to discuss to someone your future wishes in advance? Why? Do you wish to give authority on your behalf to someone? Why?
  • Barriers and facilitators for advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: In your opinion, what makes it easier or what would make it easier to talk about advance care planning? In your opinion, what makes it harder to talk about advance care planning?
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Interviews With Older People From Turkish Origin in Belgium About Advance Care Planning
Official Title  ICMJE Advance Care Planning Among Older People From Turkish Origin in Belgium: An Exploratory Interview Study
Brief Summary

Advance care planning (ACP) enables individuals to define goals and preferences for future medical treatment and care, to discuss these goals and preferences with family and health-care providers, and to record and review these preferences if appropriate. Research has shown that most Western patients express the need about what ACP entails.

Ethnicity creates an important cultural impact on how people look at life and death, so that there is an influence on making decisions about end-of-life care. The Turkish ethnic group is one of the largest visible non-Western minority groups in Western countries. Studies on how ACP is perceived among patients from Turkish origin are lacking.

The objective of this study is exploring the knowledge, experiences, point of views, preferences, attitudes, facilitators and barriers concerning advance care planning of older people from Turkish origin in Belgium. Semi-structured interviews (in the native Turkish language) will be used.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description:
One to one Interviews
Masking: None (Open Label)
Primary Purpose: Other
Condition  ICMJE
  • Advance Care Planning
  • Ethnic Minorities
  • Turkish Origin
  • Advance Medical Directives
  • Muslims
  • Living Will
Intervention  ICMJE Other: Interview
One to one interview
Study Arms  ICMJE Interview
One to one interviews with older people from Turkish origin in Belgium
Intervention: Other: Interview
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: April 25, 2019)
30
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE March 31, 2021
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

People:

  • with Turkish origin who live in Belgium and are older than 65 years
  • who have also given informed consent to participate in this qualitative interview study

Exclusion Criteria:

  • Patients who are terminal ill which means having a life-limiting disease with irreversible decline and expected survival in terms of months or less. (41)
  • Having cognitive impairment
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 65 Years and older   (Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Hakki Demirkapu, MD +32474873604 hakki.demirkapu@vub.be
Contact: Petra Van Den Borre +32(0)2 477 43 11 Petra.Van.Den.Borre@vub.be
Listed Location Countries  ICMJE Belgium
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03930823
Other Study ID Numbers  ICMJE ACP-TR-1-2018
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Universitair Ziekenhuis Brussel
Study Sponsor  ICMJE Universitair Ziekenhuis Brussel
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Hakki Demirkapu, MD Vrije Universiteit Brussel
PRS Account Universitair Ziekenhuis Brussel
Verification Date April 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP